| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...864265L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0064265 |
| P8608 | Fatcat ID | release_d3hbbpkrfzegzocdxgrgbwnpxu |
| P932 | PMC publication ID | 3669357 |
| P698 | PubMed publication ID | 23741311 |
| P5875 | ResearchGate publication ID | 237061071 |
| P2093 | author name string | Qi Wang | |
| Xin Zhao | |||
| Li Zhu | |||
| Boquan Jin | |||
| Lawrence F Brass | |||
| Qingyu Wu | |||
| Ningzheng Dong | |||
| Yuxin Wang | |||
| Wenxiu Yi | |||
| Xiaorong Tang | |||
| Shengjie Zhang | |||
| Qiongyu Lu | |||
| Haibo Gu | |||
| P2860 | cites work | Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor | Q21263141 |
| Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration | Q24290930 | ||
| Suppression of bone formation by osteoclastic expression of semaphorin 4D | Q24294299 | ||
| Interplay between scatter factor receptors and B plexins controls invasive growth | Q24295561 | ||
| Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred | Q24534800 | ||
| Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity, inducing growth cone collapse | Q24550822 | ||
| Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling | Q28140151 | ||
| Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses | Q28189775 | ||
| Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis | Q28205197 | ||
| The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras | Q28275924 | ||
| Non-cell autonomous expression of TNF-alpha-converting enzyme ADAM17 is required for normal lymphocyte development | Q28591577 | ||
| Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100 | Q29036802 | ||
| Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis | Q30494712 | ||
| Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D. | Q30498048 | ||
| Plasma soluble corin in patients with heart failure. | Q33887635 | ||
| Control of bone resorption by semaphorin 4D is dependent on ovarian function | Q34064555 | ||
| Effects of anticoagulants on human plasma soluble corin levels measured by ELISA. | Q34188582 | ||
| Diabetes mellitus: a hypercoagulable state | Q34190414 | ||
| MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. | Q34598008 | ||
| Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling | Q35396616 | ||
| Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury | Q35616359 | ||
| Corin in clinical laboratory diagnostics | Q35634038 | ||
| Systemic inflammation in heart failure--the whys and wherefores | Q36526913 | ||
| Semaphorins and their receptors in immune cell interactions. | Q37034914 | ||
| Expression and localization of tumour necrosis factor-α and its converting enzyme in human abdominal aortic aneurysm | Q54746754 | ||
| Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis | Q73069760 | ||
| Heart failure | Q73397364 | ||
| Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses | Q73919451 | ||
| Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells | Q74500047 | ||
| [Preparation and identification of monoclonal antibodies against CD100 molecule] | Q80063435 | ||
| CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis | Q80142605 | ||
| Molecular dissection of the semaphorin 4D receptor plexin-B1-stimulated R-Ras GTPase-activating protein activity and neurite remodeling in hippocampal neurons | Q81152629 | ||
| Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively | Q81475161 | ||
| Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis | Q82354361 | ||
| Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients | Q83228561 | ||
| Rho-mediated activation of PI(4)P5K and lipid second messengers is necessary for promotion of angiogenesis by Semaphorin 4D | Q84021120 | ||
| Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice | Q84334793 | ||
| Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression. | Q37069435 | ||
| Antithrombotic therapy for heart failure in sinus rhythm | Q37593135 | ||
| Roles of Sema4D and Plexin-B1 in tumor progression | Q37790755 | ||
| The role of inflammation in heart failure: new therapeutic approaches | Q37835550 | ||
| Impact of diabetes on postinfarction heart failure and left ventricular remodeling | Q37917623 | ||
| Semaphorin 4D/Plexin-B1 stimulates PTEN activity through R-Ras GTPase-activating protein activity, inducing growth cone collapse in hippocampal neurons | Q41883384 | ||
| Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. | Q45003993 | ||
| Plexin-B2 controls the development of cerebellar granule cells. | Q46446663 | ||
| A systematic expression analysis implicates Plexin-B2 and its ligand Sema4C in the regulation of the vascular and endocrine system. | Q51908264 | ||
| Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. | Q52536603 | ||
| Heart failure | Q53998058 | ||
| Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis. | Q54468855 | ||
| Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer. | Q54570073 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e64265 | |
| P577 | publication date | 2013-05-31 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Increased levels of plasma soluble Sema4D in patients with heart failure | |
| P478 | volume | 8 |
| Q57490032 | CD100 Effects in Macrophages and Its Roles in Atherosclerosis |
| Q64108771 | Correction: Increased Levels of Plasma Soluble Sema4D in Patients with Heart Failure |
| Q50248511 | Genome-wide analysis identifies an african-specific variant in SEMA4D associated with body mass index |
| Q47791314 | Netrins & Semaphorins: Novel regulators of the immune response. |
| Q55444717 | Neuroimmune semaphorins as costimulatory molecules and beyond. |
| Q52655048 | Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype. |
| Q51741939 | Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure? |
| Q33717215 | β-adrenergic receptor-dependent alterations in murine cardiac transcript expression are differentially regulated by gefitinib in vivo |
Search more.